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Experimental Procedures.
Mesylate 13. To a solution of indole 10 4 (500 mg, 1.14 mmol, 1.0 equiv) in THF (38.0 mL) at -78 °C was added a solution of LiAlH 4 (1.0 M in THF, 3.44 mL, 3.44 mmol, 3.0 equiv) in a dropwise manner. After stirring at -78 °C for 5 min, the solution was then allowed to warm to 0 ºC. After 20 min, the reaction was slowly quenched at 0 °C by the dropwise addition of a saturated solution of aqueous Rochelle's salt (30 mL), and then allowed to warm to 23 ºC. The resulting biphasic mixture was stirred at room temperature for 30 min, transferred to a separatory funnel with EtOAc (30 mL) and H 2 O (30 mL), and extracted with EtOAc (3 x 20 mL). The organic layers were combined, dried over Na 2 SO 4 , and evaporated under reduced pressure. The resulting residue was used in the subsequent step without further purification.
To a flask containing the crude product (382 mg, 0.87 mmol, 1.0 equiv) from the previous step was added DMAP (637 mg, 5.22 mmol, 6.0 equiv) and Ms 2 O (409 mg, 2.35 mmol, 2.7 equiv) as solids. The flask was flushed with N 2 , and CH 3 CN (7.77 mL) was added. The reaction mixture was allowed to stir at room temperature. After 2 h the reaction was filtered by passage through a plug of silica gel (5:1 hexanes:EtOAc eluent) to afford mesylate 13 (413 mg, 92% yield, over two steps) as a white foam. Mesylate 13: mp: 71.5 ºC; R f 0.53 (5:1 hexanes:EtOAc); 1 H NMR (500 MHz, CDCl 3 ): δ 7.17 (dd, J = 8.1, 0.6, 1H), 7.06 (dd, J = 8.1, 7.2, 1H), 6.95 (s, 1H), 6.66 (d, J = 7.1, 1H), 5.79 (app t, J = 5.8, 1H), 4.92 (dd, J = 17.5, 1.1, 1H), 4.78 (dd, J = 11.0, 1.1, 1H), 4.44 (dd, J = 17.4, 10.9, 1H), 4.77 (s, 3H), 3.64 (dd, J = 12.3, 4.2, 1H), 3.33 (d, J = 5.4, 1H), 2.85 (s, 3H), 2.55-2.48 (m, 1H), 2.18 (ddd, J = 14.7, 4.0, 2.7, 1H), 1.95 (ddd, J = 14.7, 12.4, 5 .6, 1H), 1.57 (s, 3H), 1.42 (s, 3H), 1.36 (s, 3H), 0.73 (s, 9H), -0.16 (s, 3H), -0.38 (s, 3H); 13 C NMR (125 MHz, CDCl 3 ): δ 146. 8, 136.7, 130.5, 126.4, 125.7, 124.4, 124.2, 120.5, 112.5, 107.8, 82.4, 68.2, 57.7, 49.2, 48.7, 40.5, 39.1, 37.4, 33.0, 32.8, 32.0, 25.9, 18.0, 16.1, -4.0, -4.6; IR (film): 2952 IR (film): , 2895 IR (film): , 1607 IR (film): , 1533 IR (film): , 1472 Oxabicycle 14. To a Schlenk tube containing a solution of mesylate 13 (118 mg, 0.23 mmol, 1.0 equiv) in THF (5.8 mL) was added TBAF (1.0 M in THF, 681 µL, 0.68 mmol, 3.0 equiv) in a dropwise manner. The Schlenk tube was then sealed and heated to 80 °C. After 21 h, the solution was allowed to cool to 23 ºC and then filtered by passage over a plug of silica gel (EtOAc eluent, 30 mL). The filtrate was concentrated and the resulting residue was purified by flash chromatography (9:1 hexanes:EtOAc) to afford oxabicycle 14 (56 mg, 84% yield) as a white solid. Oxabicycle 14: mp: 108.8 ºC; R f 0.66 (3:1 hexanes:EtOAc); 1 H NMR (500 MHz, CDCl 3 ): δ 7.16-7.08 (m, 2H), 6.91 (s, 1H), 6.72 (d, J = 6.4, 1H), 4.93 (app t, J = 4.4, 1H), 4.75-4.71 (m, 1H), 4.65-4.59 (m, 1H), 4.55-4.52 (m, 1H) , 4.16 (d, J = 6.1, 1H), 3.75 (s, 3H), 3.46 (d, J = 5.3, 1H), 2.44-2.34 (m, 1H), 1. 89-1.83 (ddd, J = 23.8, 11.8, 6 .3, 1H), 1. 64-1.60 (dd, J = 12.4, 8.5, 1H) , 1.43 (s, 3H), 1.37 (s, 3H), 1.23 (s, 3H); 13 C NMR (500 MHz, CDCl 3 ) δ 140. 7, 137.4, 131.3, 126.2, 124.6, 122.0, 121.5, 120.5, 114.3, 107.3, 87.2, 82.2, 59.8, 55.7, 53.0, 35.9, 34.9, 32.9, 28.7, 28.4, 27.5; IR (film): 2962 IR (film): , 2904 IR (film): , 2864 IR (film): , 1632 IR (film): , 1541 IR (film): , 1456 Oxindole 15. To a solution of indole 14 (137 mg, 0.44 mmol, 1.0 equiv) in CH 2 Cl 2 (8.2 mL) at 0 ºC was added NBS (80.0 mg, 0.45 mmol, 1.01 equiv) in one portion. The reaction vial was flushed with N 2 , and then allowed to stir at 0 ºC. After 15 min, solid NaHCO 3 (137 mg, 100 wt %) was added in one portion. The reaction was removed from the 0 ºC bath and allowed to stir at room temperature for 5 min. The resulting suspension was then concentrated under reduced pressure. Absolute ethanol (7.0 mL) and concentrated aqueous HCl (7.0 mL) were added. After heating to 80 ºC for 2 h, the reaction mixture was cooled to room temperature and transferred to a separatory funnel with H 2 O (14 mL) and EtOAc (14 mL). To the separatory funnel was slowly added solid NaHCO 3 until gas evolution was no longer observed. The resulting biphasic mixture was extracted with EtOAc (3 x 14 mL) and the organic layers were combined, dried over Na 2 SO 4 , and evaporated under reduced pressure. The resulting residue was purified by flash chromatography (9:1 hexanes:EtOAc) to afford oxindole 15 (120 mg, 83% yield) as a white solid. Oxindole 15: mp: 138.4 ºC; R f 0.59 (1:1 hexanes:EtOAc); 1 H NMR (500 MHz, CDCl 3 ): δ 7.19 (ddd, J = 7.8, 7.8, 0.6, 1H), 6.76 (d, J = 7.5, 1H), 6.70 (d, J = 7.7, 1H), 5.53 (dd, J = 17.9, 11.2, 1H) , 4.96 (dd, J = 11.2, 1.2, 1H), 4.84 (dd, J = 17.9, 1.2, 1H), 4.47 (app t, J = 5.0, 1H), 4.38 (d, J = 5.8, 1H), 3.46 (s, 1H), 3.19 (s, 3H), 3.02 (d, J = 4.5, 1H), 2.31-2.22 (m, 1H), 2.11 (dd, J = 12.9, 6.6, 1H), 1.98 (ddd, J = 12.2, 12.2, 5.8, 1H) , 1.43 (s, 3H), 1.35 (s, 3H), 0.73 (s, 3H); 13 C NMR (125 MHz, CDCl 3 : δ 176. 6, 144.2, 140.6, 134.3, 128.1, 126.5, 126.2, 116.4, 106.6, 87.0, 80.8, 60.3, 56.5, 51.2, 49.9, 37.0, 31.9, 27.8, 27.6, 26.3, 23.2; IR (film): 2962 IR (film): , 1703 IR (film): , 1605 IR (film): , 1469 IR (film): , 1324 NO 2 , 324.19635; found 324.19514; [α] 21.4 D +28.20° (c = 1.000, CHCl 3 ).
The structure of 15 was confirmed by a 2D-NOESY experiment, as the following interactions were observed:
Diene 16 and Alkyl Chloride 17. A solution of oxindole 15 (6.1 mg, 0.019 mmol, 1.0 equiv) in CH 2 Cl 2 (1.89 mL) was cooled to -78 °C. A solution of BCl 3 (1.0 M in CH 2 Cl 2 , 145.4 µL, 0.14 mmol, 7.7 equiv) was added in a dropwise manner. The resulting solution was allowed to stir at -78 °C. After 30 min, the solution was allowed to warm to 0 ºC. After 2 additional hours, the solution was warmed to room temperature. After 4 h, the reaction was quenched by the addition of a saturated aqueous solution of NaHCO 3 (1 mL), transferred to a separatory funnel with EtOAc (6 mL) and H 2 O (4 mL), and extracted with EtOAc (3 x 3 mL). The organic layers were combined, dried over Na 2 SO 4 , and evaporated under reduced pressure. The resulting residue was purified by preparative thin layer chromatography (1:1 hexanes:EtOAc) to afford diene 16 (1.1 mg, 18% yield) and alkyl chloride 17 (0.8 mg, 12% yield) as amorphous solids. Diene 16: R f 0.60 (1:1 hexanes:EtOAc); 1 H NMR (500 MHz, CDCl 3 ): δ 7.21 (ddd, J = 7.8, 7.8, 0.6, 1H), 6.91 (d, J = 7.3, 1H), 6.76 (dd, J = 17.2, 11.0, 1H), 6.67 (d, J = 7.8, 1H), 5.32 (d, J = 17.2, 1H), 5.09 (d, J = 11.1, 1H), 4.24 (br. s, 1H), 3.32 (s, 1H), 3.25 (s, 1H), 3.14 (s, 3H), 2.73 (d, J = 18.7, 1H), 2.56 (dd, J = 18.7, 7.9, 1H), 2.02 (d, J = 7.9, 1H), 1.79 (d, J = 6.7, 1H), 1.68 (s, 3H), 1.54 (s, 3H), 0.73 (s, 3H); 13 C NMR (125 MHz, CDCl 3 ): δ 176. 4, 144.4, 135. 8, 134.0, 128.9, 128.1, 126.6, 126.4, 123.5, 112.9, 106.4, 67.5, 54.4, 50.9, 49.1, 39.0, 28.0, 26.1, 22.5, 21.2, 17.8; IR (film): 3412, 2969 IR (film): 3412, , 1690 IR (film): 3412, , 1608 IR (film): 3412, , 1470 2, 146.3, 145.0, 138.7, 128.0, 126.8, 124.1, 114.8, 106.8, 69.7, 59.3, 58.2, 56.8, 54.8, 46.5, 39.4, 27.3, 26.3, 25.3, 23.3, 19. .0 equiv). The vial was flushed with N 2 , sealed and stirred at room temperature. After 19 h, solid NaIO 4 (89 mg, 0.42 mmol, 3.0 equiv) was added in one portion and the reaction mixture was stirred at room temperature. After 13 min, the reaction mixture was quenched with a saturated aqueous solution of Na 2 S 2 O 3 (1 mL) and stirred vigorously at room temperature. After 30 min the resulting mixture was transferred to a test tube with EtOAc (5 mL) and H 2 O (5 mL). The resulting biphasic mixture was extracted with EtOAc (3 x 3 mL). The organic layers were combined, dried over Na 2 SO 4 , and evaporated under reduced pressure. The resulting residue was purified by preparative thin layer chromatography ( 6, 175.9, 144.7, 131.8, 128.8, 125.65, 125.60, 107.4, 84.6, 81.0, 59.1, 58.9, 56.0, 49.3, 36.9, 282, 27.5, 26.4, 25.4, 23 175.8, 144.9, 133.8, 128.9, 125.1, 124.8, 107.5, 69.6, 61.8, 57.4, 53.8, 51.6, 50.5, 39.5, 31.3, 26.4, 26.1, 25.9, 22. To a vial containing SI-1 (17.9 mg, 0.038 mmol, 1.0 equiv) was added the Petasis reagent (1.0 M in PhMe, 444 µL, 0.444 mmol, 11.8 equiv) in the absence of light. The reaction vessel was then sealed and heated to 60 °C. After 4.5 h the reaction was cooled to room temperature and filtered by passage over a plug of silica gel (3:1 hexanes:EtOAc eluent, 15 mL). The filtrate was evaporated under reduced pressure and the resulting residue was purified by preparative thin layer chromatography (3:1 hexanes:EtOAc) to afford silyl ether 20 (15.6 mg, 88% yield) as an amorphous solid. Silyl Ether 20: R f 0.57 (3:1 hexanes:EtOAc); 1 H NMR (500 MHz, CDCl 3 ): δ 7.14 (dd, J = 7.7, 7.7, 1H), 6.65 (d, J = 7.6, 1H), 6.62 (d, J = 7.6, 1H), 5.65 (dd, J = 17.2, 10.9, 1H), 5.15 (dd, J = 12.7, 4.5, 144.5, 138.6, 138.3, 128.0, 125.5, 124.4, 115.0, 106.3, 70.0, 65.3, 60.7, 54.8, 50.6, 44.4, 39.7, 31.5, 29.7, 26.3, 25.9, 22.6, 7.1, 4 Carbamate 8. To a flask containing silyl ether 20 (5.4 mg, 0.011 mmol, 1.0 equiv), was added absolute ethanol (542 µL) and concentrated aqueous HCl (542 µL). The solution was then allowed to stir at room temperature. After 20 min, the reaction mixture was transferred to a separatory funnel with EtOAc (6 mL). To the funnel was slowly added a saturated aqueous solution of NaHCO 3 (5 mL) until gas evolution was no longer observed. The resulting biphasic mixture was extracted with EtOAc (3 x 3 mL) and the organic layers were combined, dried over Na 2 SO 4 , and evaporated under reduced pressure. The resulting residue was purified by preparative thin layer chromatography To a solution of SI-2 (4.1 mg, 0.011 mmol, 1.0 equiv) in CH 2 Cl 2 (228 µL) at 0 °C was added trichloroacetyl isocyanate (1.7 µL, 0.0142 mmol, 1.25 equiv) in a dropwise manner. The resulting mixture was allowed to stir at 0 °C for 5 min, and then at room temperature for 30 min. The solvent was evaporated under reduced pressure. To the resulting residue was added MeOH (228 µL), followed by K 2 CO 3 (8.6 mg, 0.0626 mmol, 5.5 equiv) in one portion. The vial was flushed with N 2 and left to stir at room temperature. After 1 h, the reaction was quenched with a saturated aqueous solution of NH 4 Cl (1 mL), and the resulting biphasic mixture was transferred to a separatory funnel with EtOAc (6 mL) and H 2 O (4 mL). After extracting with EtOAc (3 x 3 mL), the organic layers were combined, dried over Na 2 SO 4 , and evaporated under reduced pressure. The resulting residue was purified by preparative thin layer chromatography (1:1 hexanes:EtOAc) to afford carbamate 8 (4.6 mg, quant. yield) as an amorphous solid. 144.5, 137.9, 137.0, 128.2, 125.7, 124.4, 115.6, 106.7, 73.2, 64.6, 57.0, 51.1, 50.7, 44.1, 39.7, 31.0, 29.4, 26.4, 25.7, 22.3 Oxazolidinone 21. A 1-dram vial containing CH 3 CN, a second 1-dram vial charged with bathophenanthroline (3.8 mg, 0.011 mmol, 1.0 equiv), and a third 1-dram vial containing carbamate 8 (4.6 mg, 0.011 mmol, 1.0 equiv) and PhI(OAc) 2 (14.7 mg, 0.046 mmol, 4.0 equiv) were transferred into the glovebox. AgOTf (2.9 mg, 0.011 mmol, 1.0 equiv) and CH 3 CN (200 µL) were added to the vial containing the bathophenanthroline, and the resulting suspension was allowed to stir at room temperature for 20 min. Next, CH 3 CN (126 µL) was added to the vial containing the carbamate, and the AgOTf/bathophenanthroline suspension was also added to this vial. The vial was then sealed, removed from the glovebox, and the resulting mixture was heated to 50 °C. After 20.5 h, the reaction was cooled to room temperature and filtered by passage over a plug of celite (EtOAc eluent, 10 mL). The filtrate was evaporated under reduced pressure, and the resulting residue was purified by preparative thin layer chromatography (1:2:2 PhH:CH 2 Cl 2 :Et 2 O) to afford oxazolidinone 21 (1.6 mg, 35% yield) as an amorphous solid and recovered carbamate 8 (2.0 mg, 43% yield). 144.7, 137.9, 136.4, 128.7, 126.7, 123.0, 116.0, 107.3, 78.7, 67.5, 61.7, 53.6, 52.7, 44.4, 41.3, 40.2, 28.3, 26.5, 21.1, 17.8 To a flask containing alkyl chloride 19 (15.1 mg, 0.042 mmol, 1.0 equiv) was added solid NaHCO 3 (17.5 mg, 0.054 mmol, 5.0 equiv) in one portion. The reaction vessel was flushed with N 2 , and then CH 2 Cl 2 (834 µL) was added. To the resulting suspension was added the Dess-Martin periodinane reagent (23.0 mg, 0.21 mmol, 1.3 equiv) in one portion. The flask was flushed with N 2 , and the reaction mixture was allowed to stir at room temperature. After 1 h, the reaction mixture was diluted with a 1:1 mixture of saturated aqueous NaHCO 3 and saturated aqueous Na 2 S 2 O 3 (1.0 mL). The resulting biphasic mixture was vigorously stirred until both layers appeared clear. The mixture was then transferred to a separatory funnel with EtOAc (6 mL) and H 2 O (4 mL), and then extracted with EtOAc (3 x 3 mL). The organic layers were combined, dried over Na 2 SO 4 , and evaporated under reduced pressure. The resulting residue was purified by preparative thin layer chromatography (1:1 hexanes:EtOAc) to afford SI-3 (12.6 mg, 84% yield) as a white foam. SI-3: R f 0.88 (1:3 hexanes:EtOAc); 1 H NMR (500 MHz, C 6 D 6 ): δ 9.06 (d, J = 1.2, 1H), 6.76 (ddd, J = 7.8, 7.8, 0.8, 1H), 6.33 (d, J = 7.6, 1H), 6.00 (d, J = 7.5, 1H), 3.41 (d, J = 2.2, 1H), 3.40 (s, 1H), 3.35 (ddd, J = 13.5, 4.5, 0.9, 1H), 2.84 (m, 1H), 2.52 (s, 3H), 2.28-2.21 (m, 1H), 1.93 (ddd, J = 14.6, 10.7, 4.6, 1H), 1.40 (s, 3H), 1.13 (s, 3H), 0.70 (s, 3H).
20, R = TES
To a vial containing methyl triphenylphosphonium bromide (373 mg, 1.04 mmol, 15.0 equiv) was added THF (1.7 mL). The reaction vessel was cooled to 0 °C and NaHMDS (1.0 M in THF, 836 µL, 0.84 mmol, 12.0 equiv) was added in a dropwise manner. The vial was allowed to warm to room temperature and left to stir for 20 min. A solution of SI-3 (25.0 mg, 0.070 mmol, 1.0 equiv) in THF (2.4 mL) was added dropwise in three portions and the reaction was left to stir at room temperature. After 30 min, the reaction was quenched by the the addition of a saturated aqueous solution of NH 4 Cl (5 mL). The resulting biphasic mixture was transferred to a separatory funnel with EtOAc (15 mL) and H 2 O (10 mL). After extracting with EtOAc (3 x 15 mL), the organic layers were combined, dried over MgSO 4 , and evaporated under reduced pressure. The resulting crude mixture was filtered by passage over a plug of silica gel (1:1 hexanes:EtOAc, 40 mL). The filtrate was evaporated under reduced pressure and the resulting residue was purified by flash chromatography ( 6, 175.3, 144.6, 136.2, 132.1, 129.0, 125.2, 124.4, 117.9, 107.3, 68.9, 64.5, 62.5, 50.9, 48.6, 41.8, 32.6, 29.7, 26.5, 25.0, 22.2; IR (film): 1702 IR (film): , 1607 IR (film): , 1591 IR (film): , 1465 
SI-3
O H Carbamate 23. To a solution of ketone 22 (87 mg, 0.244 mmol, 1.0 equiv) in THF (24.4 mL) at -78 °C was added a solution of LiAlD 4 (1.0 M in THF, 731 µL, 0.731 mmol, 3.0 equiv) in a dropwise manner. After stirring at -78 °C for 10 min, the solution was then allowed to warm to 0 ºC. After 12 min, the reaction was quenched at 0 °C by the slow addition of a saturated solution of aqueous Rochelle's salt (10 mL), and then allowed to warm to 23 ºC. The resulting biphasic mixture was stirred at room temperature for 1 h, transferred to a separatory funnel with EtOAc (10 mL) and H 2 O (10 mL), and extracted with EtOAc (3 x 10 mL). The organic layers were combined, dried over MgSO 4 , and evaporated under reduced pressure. The resulting residue was used in the subsequent step without further purification.
To a flask containing the crude residue from the previous step was added CH 2 Cl 2 (4.9 mL). The reaction vessel was cooled to 0 ºC and trichloroacetyl isocyanate (36.3 µL, 0.305 mmol, 1.25 equiv) was added in a dropwise manner. The resulting mixture was allowed to stir at 0 °C for 5 min, and then at room temperature for 20 min. The solvent was evaporated under reduced pressure. To the resulting residue was added MeOH (4.9 mL) and solid K 2 CO 3 (185 mg, 1.34 mmol, 5.5 equiv) in one portion. The reaction was flushed with N 2 and left to stir at room temperature for 1 h. The reaction was quenched by the addition of a solution of saturated aqueous NH 4 Cl (5.0 mL), and the resulting biphasic mixture was transferred to a separatory funnel with EtOAc (10 mL) and H 2 O (10 mL). After extracting with EtOAc (3 x 10 mL), the organic layers were combined, dried over MgSO 4 , and evaporated under reduced pressure. The resulting residue was purified by flash chromatography (2:1 → 1:1 hexanes:EtOAc) to afford carbamate 23 (98 mg, quantitative yield, over two steps) as a white solid. Carbamate 23: mp: 102.8 ºC; R f 0.56 (2:1 EtOAc:hexanes); 1 H NMR (500 MHz, CDCl 3 ): δ 7.14 (dd, J = 7.7, 7.7, 1H), 6.68 (d, J = 7.6, 1H), 6.61 (d, J = 7.7, 1H), 5.72 (dd, J = 17.1, 10.9, 1H), 4.87-4.84 (m, 2H), 4.47-4.4 (m, 3H), 3.69 (s, 1H), 3.19 (s, 3H), 3.14 (s, 1H), 2.54-2.46 (m, 2H), 2.39-2.29 (m, 1H), 1.51 (s, 3H), 1.45 (s, 3H), 0.90 (s, 3H); 2 H NMR (77 MHz, CDCl 3 ) δ 5.43 (br. s, 1D); 13 C NMR (125 MHz, CDCl 3 ): δ 176. 3, 155.8, 144.3, 137.9, 137.5, 127.8, 126.5, 125.3, 116.1, 106.6, 64.1, 56.1, 51.5, 46.6, 46.3, 39.1, 33.0, 29.0, 26.7, 26.4, 24.0; IR (film): 1724 IR (film): , 1701 IR (film): , 1607 IR (film): , 1467 IR (film): , 1376 Oxazolidinone 24. A 1-dram vial containing CH 3 CN, a second 1-dram vial charged with bathophenanthroline (13 mg, 0.039 mmol, 1.0 equiv), and a third 1-dram vial containing carbamate 23 (15.8 mg, 0.039 mmol, 1.0 equiv) and PhI(OAc) 2 (50 mg, 0.157 mmol, 4.0 equiv) were transferred into the glovebox. AgOTf (10 mg, 0.039 mmol, 1.0 equiv) and CH 3 CN (550 µL) were added to the vial containing the bathophenanthroline, and the resulting suspension was allowed to stir at room temperature for 20 min. Next, CH 3 CN (550 µL) was added to the vial containing the carbamate, and the AgOTf/bathophenanthroline suspension was also added to this vial. The vial was then sealed, removed from the glovebox, and the resulting mixture was heated to 50 °C. After 24 h, the reaction was cooled to room temperature and filtered by passage over a plug of silica gel (EtOAc eluent, 10 mL). The filtrate was evaporated under reduced pressure, and the resulting residue was purified by preparative thin layer chromatography (2:1:1 benzene:Et 2 O:CH 2 Cl 2 ) to afford oxazolidinone 24 (8.7 mg, 55% yield) as a white solid and recovered ketone 22 (1 mg, 10% yield). 1, 159.5, 143.6, 138.7, 137.5, 128.2, 125.3, 124.1, 115.9, 107.0, 70.3, 63.1, 53.3, 47.9, 45.5, 38.2, 32.3, 27.1, 26.4, 23.3, 21. Formamide 25. Two 1-dram vials were charged with 24 (7.0 mg, 0.017 mmol, 1.0 equiv each) and taken into the glovebox. Each reaction vessel was charged with Schwartz' reagent (5.9 mg, 0.023 mmol, 1.3 equiv each) and THF (1.74 mL each), the latter of which had previously been taken through six freeze-pump-thaw cycles. The reaction vessels were sealed and left to stir at room temperature. After 14 h, the reaction vials were removed from the glovebox and quenched with a saturated aqueous solution of NH 4 Cl (1 mL for each vial). The resulting biphasic mixtures were transferred to a test tube with EtOAc (2 mL) and brine (1 mL). After extracting with EtOAc (3 x 2 mL). The The resulting residue was purified by preparative thin layer chromatography (1:1 hexanes:acetone) to afford SI-3 5 (7.2 mg, 51% yield) as a white solid and recovered oxazolidinone 24 (3.1 mg, 22% yield). SI-3: R f 0.09 (1:1 hexanes:EtOAc); 1 H NMR (500 MHz, CDCl 3 ): 6 8. 3-8.25 (m, 1.36H), 7.95 (s, 0.47H), 7.31-7.27 (m, 1.25H), 6.96 (d, J = 8.2, 0.41H), 6.87 (d, J = 8.1, 1H), 6.78-6.73 (m, J = 8.3, 2 .0H), 6.22 (s, 1H), 6.10 (d, J = 11.2, 0.41H), 5.92 (dd, J = 17.8, 11.4, 1H), 5.88-5.80 (m, 0.87H), 5.05-4.97 (m, 0.8H), 4.94-4.85 (m, 3H), 4.79 (dd, J = 9.9, 5.5, 1H), 4.48 (dd, J = 9.2, 5.2, 0.5H), 4.33 (d, J = 8.2, 5.7, 0.38H), 4.20 (s, 0.36H), 4.10 (s, 0.38H), 4.06 (s, 1H), 3.23-3.19 (m, 5.7H), 2.73-2.49 (m, 4 .5H), 2.44-2.36 (m, 1.5H), 1.57 (s, 3H), 1.56 (s, 3.5H), 1.52 (s, 4.4H), 1.50 (s, 1.71H), 1.23 (s, 1.34H), 1.18 (s, 3H), 0.95 (s, 1.4H).
A 1-dram vial was charged with SI-3 (5.2 mg, 0.013 mmol, 1.0 equiv) and solid NaHCO 3 (5.4 mg, 0.065 mmol, 5.0 equiv) in one portion. The reaction vessel was flushed with N 2 , and then CH 2 Cl 2 (260 µL) was added. To the resulting suspension was added the Dess-Martin periodinane reagent (7.1 mg, 0.017 mmol, 1.3 equiv) in one portion. The flask was flushed with N 2 , and the reaction mixture was allowed to stir at room temperature. After 1 h, the reaction mixture was diluted with a 1:1 mixture of saturated aqueous NaHCO 3 and saturated aqueous Na 2 S 2 O 3 (1.0 mL). The resulting biphasic mixture was vigorously stirred until both layers appeared clear. The mixture was then transferred to a test tube with EtOAc (2 mL) and brine (2 mL), and then extracted with EtOAc (3 x 2 mL). The organic layers were combined, dried over MgSO 4 , and evaporated under reduced pressure. The resulting residue was purified by flash chromatography ( 8, 174.3, 167.3, 144.0, 137.2, 133.7, 128.4, 126.7, 124.8, 118.2, 108.1, 71.5, 62.2, 60.2, 55.0, 49.8, 38.2, 31.8, 26.3, 26.1, 22.9, 20.9 N-Methylwelwitindolinone B Isothiocyanate (2) . To a solution of formamide 25 (3.3 mg, 0.008 mmol, 1.0 equiv) in 1:1 THF/PhH (660 µL) was added Burgess reagent (2.0 mg, 0.008 mmol, 1.0 equiv). The reaction vessel was purged with N 2 , and then sealed and left to stir at room temperature. After stirring for 1 h, an additional portion of Burgess reagent (0.5 mg, 0.002 mmol, 0.25 equiv) was added. After stirring at room temperature for 30 min, a final portion of Burgess reagent (0.5 mg, 0.002 mmol, 0.25 equiv) was added and the resulting solution was stirred at room temperature. After 25 min, the reaction was filtered by passage over a plug of silica gel (EtOAc eluent, 6 mL). The filtrate was evaporated under reduced pressure and the resulting residue was purified by flash chromatography (5:1:1 hexanes:Et 2 O:CH 2 Cl 2 ) to afford SI-4 (3.2 mg, quant. yield) as a white solid. SI-4: R f 0.55 (1:1:1 hexanes:Et 2 O:CH 2 Cl 2 ); 1 H NMR (500 MHz, C 6 D 6 ): δ 7.41 (d, J = 8.3, 1H), 6.86 (dd, J = 8.0, 8.0, 1H), 6.04 (d, J = 7.7, 1H), 5.82 (dd, J = 17.2, 11.0, 1H), 4.95-4.81 (m, 2H), 3.83 (s, 1H), 3.43 (dd, J = 6.4, 6.2, 1H), 2.55 (s, 3H), 2.36 (dd, J = 9.9, 3.6, 1H), 2.19-2.11 (m, 1H), 1.91-1.81 (m, 1H), 1.46 (s 3H), 1.26 (s, 3H), 0.75 (s, 3H).
(-)-
Two 1-dram vials containing SI-4 (2.9 mg, 0.008 mmol, 1.0 equiv each) were charged with powdered Se (1.8 mg, 0.023 mmol, 3.0 equiv each) and S 8 (1.9 mg, 0.590 mmol, 76.4 equiv each). The reaction vessels were purged with N 2 and to each vessel was added THF (584 µL, previously sparged with N 2 for 20 min) and NEt 3 (81 µL, 0.590 mmol, 26.4 equiv). Each reaction vessel was then sealed and heated to 65 °C. After 17 h, the reaction vials were cooled to room temperature. Their contents were combined and filtered by passage over a plug of silica gel (EtOAc eluent, 6 mL). The filtrate was evaporated under reduced pressure and the resulting residue was purified by preparative thin layer chromatography (1:1:1 hexanes:Et 2 O:CH 2 Cl 2 ) to afford (-)-2 (3.4 mg, 54% yield) as a white solid. (-)-N-Methylwelwitindolinone B isothiocyanate (2): mp: 186.4 ºC; R f 0.61 (1:1 hexanes:EtOAc); 1 H NMR (500 MHz, CDCl 3 ): δ 7.34 (ddd, J = 8.3, 0.8, 1H), 7.25 (dd, J = 8.3, 0.9, 1H), 6.80 (d, J = 7.7, 1H), 5.99 (dd, J = 17.5, 11.1, 1H), 5.22-5.15 (m, 2H), 4.17 (app t, J = 6.3, 1H), 4.13 (s, 1H), 3.20 (s, 3H), 2.95 (app t, J = 7.2, 1H), 2.78 (app t, J = 6.5, 1H), 1.62 (s 3H), 1.48 (s, 3H), 0.83 (s, 3H); 13 C NMR (125 MHz, CDCl 3 ): δ 198. 6, 174.3, 144.1, 139.6, 136.4, 131.2, 128.8, 123.9, 122.6, 118.1, 108.3, 83.5, 62.5, 60.2, 53.3, 52.9, 39.8, 31.5, 26.4, 25.4, 24.1, 22.5; IR (film): 2969 IR (film): , 2933 IR (film): , 2049 IR (film): , 1710 IR (film): , 1607 IR (film): , 1587 IR (film): , 1460 
